A Phase III Randomized Double-Blind Placebo-Controlled Clinnical Study Evaluating the Efficacy and Safety of ALTU-135 Treatment in Patients with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Grants and Contracts Details

StatusFinished
Effective start/end date2/19/08 → 8/31/08

Funding

  • Altus Pharmaceuticals Inc.: $6,296.00